Hyperbaric Oxygen Therapy for Cluster Headaches and Migraines: What the Evidence Shows

Important: Hyperbaric oxygen therapy (the pressurized chamber) is not FDA-approved for cluster headache or migraine. This is an investigational use. The evidence is preliminary and mixed. Insurance will not cover HBOT for headache disorders. All costs are out-of-pocket. This page is not about the normobaric oxygen used to abort acute cluster attacks, which is a separate, established treatment.

If you have cluster headaches, you may already use oxygen. A mask, a tank, 100% oxygen at room pressure when an attack hits. That treatment is real and recommended. It is also not hyperbaric oxygen therapy, and the difference matters before you pay for anything. This page covers what the research found on the pressurized chamber and why it is easy to confuse the two.

Two Different Oxygen Treatments

The most common reason people land here is a mix-up, so start with the distinction.

Normobaric oxygen means breathing 100% oxygen at normal atmospheric pressure, the pressure you are sitting in right now. For cluster headache, a patient puts on a non-rebreather mask at the first sign of an attack and breathes high-flow oxygen for about fifteen minutes. It is an abortive treatment, meaning it works to stop an attack that has already started.

Hyperbaric oxygen therapy is different. You breathe oxygen inside a sealed chamber pressurized above sea level, usually somewhere between 2.0 and 2.4 ATA for the conditions HBOT is cleared to treat. The added pressure drives far more oxygen into the blood plasma than a mask at room pressure can. That is the whole point of the chamber, and it is also why a course of HBOT involves repeated scheduled sessions rather than self-administered relief at home.

So when a study or a clinic says oxygen helps cluster headache, the next question is always which oxygen. The guideline-backed answer is the mask at room pressure. The chamber is a separate question with much weaker support.

The Established Use: Normobaric Oxygen for Acute Cluster Attacks

High-flow normobaric oxygen is a first-line abortive treatment for cluster headache, and it has good evidence behind it.

Cohen et al. (2009) published a randomized controlled trial in JAMA in which patients self-administered either 100% oxygen or air at 12 liters per minute for 15 minutes at the start of an attack. About 78% of patients were pain-free at 15 minutes with oxygen, compared with about 20% with placebo air, and no significant adverse events were reported (PMID: 19996400). Major headache guidelines list inhaled oxygen as a treatment of choice for aborting acute cluster attacks.

That is normobaric oxygen, not HBOT. If you are using or considering a home oxygen setup for cluster headache, that is a conversation with your neurologist about the mask treatment, and it is not what the rest of this page is about.

What the Research Shows on Hyperbaric (Chamber) Treatment

For the pressurized chamber specifically, the evidence is limited and mixed.

The most useful summary is a Cochrane systematic review, Bennett et al. (2015), which pooled the available trials on both normobaric and hyperbaric oxygen for migraine and cluster headache (PMID: 26709672). For HBOT, the review found low-quality evidence that it may relieve pain during an acute migraine attack, and weaker, less certain evidence for an effect on acute cluster headache. The authors were explicit that the trials were small and the overall quality of evidence was low.

Two limits in that review matter for anyone weighing the chamber. First, the studies looked at aborting an attack already underway, not at preventing future ones. The review found no good evidence that HBOT prevents headaches from recurring. Second, low-quality evidence is not a green light. It means the studies that exist are too small or too flawed to be confident in, not that a benefit has been confirmed.

Migraine sits at the more-studied but still weak end of this. Cluster headache, on the chamber side specifically, has even less to go on. Neither has the kind of large, replicated, controlled trial evidence that supports HBOT’s FDA-approved uses.

Why This Distinction Gets Exploited

Cluster-headache patients are among the most oxygen-literate people who walk into a hyperbaric clinic. Many already know oxygen aborts their attacks, because the mask works for them. That makes the leap to a pressurized chamber feel logical, and some clinics market it that way.

The leap does not hold. The fact that room-pressure oxygen aborts an attack does not mean a multi-week, multi-thousand-dollar course of chamber sessions adds anything. Different delivery, different cost, different evidence base. A clinic that blurs the two, or that cites the strong normobaric-oxygen data to sell you on HBOT, is not giving you the honest picture.

If a provider promotes the chamber for headache disorders, it is fair to ask them which studies they are relying on and whether those studies used a chamber or a mask. The honest answer for the chamber is that the evidence is preliminary.

What HBOT Won’t Do for Headache Disorders

HBOT is not FDA-approved for cluster headache or migraine, and insurance will not cover it for either. At $250-450 per session out-of-pocket, a course adds up quickly. Rates change annually, so verify any figure with your facility’s billing team.

The chamber is also not a preventive. The Cochrane review found no evidence that it stops future attacks, so framing it as a way to reduce how often you get headaches is not supported. And it does not replace the standard care your neurologist manages, including the abortive oxygen mask, triptans, and the preventive medications used for cluster headache and migraine. Those have far more established evidence than the chamber does.

Frequently Asked Questions

Is HBOT covered by insurance for migraines or cluster headaches? No. Insurance won’t cover HBOT for headache disorders. It isn’t FDA-approved for this use, so all costs are out-of-pocket. Verify any rate with your facility’s billing team, as figures change annually.

Is the oxygen tank I use for cluster headaches the same as HBOT? No. A home or clinic oxygen mask delivers 100% oxygen at normal room pressure to abort an attack. HBOT delivers oxygen inside a pressurized chamber. They are different treatments, and only the mask version is in cluster-headache guidelines.

Does HBOT prevent migraines or cluster attacks? The 2015 Cochrane review (Bennett et al.) found no evidence that HBOT prevents future attacks. The limited evidence that exists looked at relieving an attack already underway, not preventing them.

What’s the difference between FDA-approved HBOT uses and investigational ones? FDA-approved conditions, such as diabetic foot wounds and decompression sickness, have strong evidence and insurance coverage. Investigational uses like headache disorders have only early or weak research support and are not covered. The does HBOT work guide explains where the evidence is strong and where it is thin.

References

Bennett, M.H., French, C., Schnabel, A., Wasiak, J., Kranke, P., Weibel, S. (2015). Normobaric and hyperbaric oxygen therapy for the treatment and prevention of migraine and cluster headache. Cochrane Database of Systematic Reviews, Issue 12, CD005219. PMID: 26709672. https://pubmed.ncbi.nlm.nih.gov/26709672/

Cohen, A.S., Burns, B., Goadsby, P.J. (2009). High-flow oxygen for treatment of cluster headache: a randomized trial. JAMA. PMID: 19996400. https://pubmed.ncbi.nlm.nih.gov/19996400/

Browse all conditions on the conditions hub. For another brain-focused investigational use, see HBOT for TBI and concussion. Before paying out-of-pocket for any off-label course, read how to think about off-label HBOT. The does HBOT work guide separates the strong evidence from the early evidence.

Medical Disclaimer: This page is for informational purposes only. It does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before pursuing any medical treatment.